About Us
Growing in the USA. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities.
Play Video
WHO WE ARE
Business Model
Significant Developments
Our Timeline
July 2018
December 2018
April 2019
Jun 2019
Jun 2020
Completion of $4.5 million financing
Enter into an agreement with Sugarleaf Farms to acquire the global brand and marketing rights to the Sugarleaf brand (outside of Washington State)
Completion of $10,830,000 debenture financing
Investment completed in Applied Cannabis Sciences Partnership. Filed three applications in New Jersey
Agreement to invest up to $1 million in Immunoflex biotech venture
Experience
Our Team
Karl Kottmeier
President and CEO
Sheldon Aberman
Chief Cannabis Officer and Director
Doug Ford
Chief Financial Officer